Literature DB >> 19630766

Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators.

C N Serhan1.   

Abstract

Using a systems approach to profile self-limited inflammatory exudates, we identified three novel families of lipid-derived mediators, coined the resolvins, protectins and most recently, the maresins that control both the magnitude and duration of inflammation. The mapping of these endogenous resolution circuits provides new avenues to probe the molecular basis of many widely occurring inflammatory diseases. This article focuses on our recent advances on the functional metabolomics of this novel genus of specialized pro-resolving mediators (SPM). SPM include resolvins, protectins and maresins and are biosynthesized from essential omega-3 fatty acid precursors. Each possesses potent multi-pronged actions that proved to be stereoselective with human cells and in animal disease models. Resolvins and protectins are also produced in bone marrow. Together, these findings suggest that defective resolution mechanism(s) may underlie some chronic inflammatory diseases. Moreover, identification of functional SPM biosynthesized during inflammation-resolution indicates that resolution is an active process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630766     DOI: 10.1111/j.1538-7836.2009.03396.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  43 in total

Review 1.  Fish oil in critical illness: mechanisms and clinical applications.

Authors:  Renee D Stapleton; Julie M Martin; Konstantin Mayer
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

Review 2.  Regulatory activity of polyunsaturated fatty acids in T-cell signaling.

Authors:  Wooki Kim; Naim A Khan; David N McMurray; Ian A Prior; Naisyin Wang; Robert S Chapkin
Journal:  Prog Lipid Res       Date:  2010-02-20       Impact factor: 16.195

Review 3.  Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.

Authors:  Charles N Serhan
Journal:  Mol Aspects Med       Date:  2017-03-03

Review 4.  Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis?

Authors:  A M Shields; G S Panayi; V M Corrigall
Journal:  Clin Exp Immunol       Date:  2011-06-14       Impact factor: 4.330

Review 5.  Infection, inflammation, and bone regeneration: a paradoxical relationship.

Authors:  M V Thomas; D A Puleo
Journal:  J Dent Res       Date:  2011-01-19       Impact factor: 6.116

6.  Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.

Authors:  Doina Ganea; Virginia Kocieda; Weimin Kong; Jui-Hung Yen
Journal:  Clin Lipidol       Date:  2011-06

7.  Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory proresolving lipid mediators.

Authors:  Brian T Kalish; Hau D Le; Jonathan M Fitzgerald; Samantha Wang; Kyle Seamon; Kathleen M Gura; Karsten Gronert; Mark Puder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-03       Impact factor: 4.052

Review 8.  Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?

Authors:  Martin D Rosenthal; Jayshil Patel; Kyle Staton; Robert G Martindale; Frederick A Moore; Gilbert R Upchurch
Journal:  Curr Gastroenterol Rep       Date:  2018-08-04

9.  Correction of MFG-E8 Resolves Inflammation and Promotes Cutaneous Wound Healing in Diabetes.

Authors:  Amitava Das; Subhadip Ghatak; Mithun Sinha; Scott Chaffee; Noha S Ahmed; Narasimham L Parinandi; Eric S Wohleb; John F Sheridan; Chandan K Sen; Sashwati Roy
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

10.  Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair.

Authors:  Giovanna Leoni; Ashfaqul Alam; Philipp-Alexander Neumann; J David Lambeth; Guangjie Cheng; James McCoy; Roland S Hilgarth; Kousik Kundu; Niren Murthy; Dennis Kusters; Chris Reutelingsperger; Mauro Perretti; Charles A Parkos; Andrew S Neish; Asma Nusrat
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.